Download the Whitepaper
Fluid-Based Biomarkers for Neurodegenerative Diseases
Over the past two decades considerable advancement has been made regarding fluid-based biomarker research in the field of neurodegeneration. It is important to have reliable biomarkers that increase the accuracy of clinical diagnosis.
In this new whitepaper, Medpace experts discuss current fluid-based biomarkers for various neurodegenerative disease pathologies.
Over the past two decades considerable advancement has been made regarding fluid-based biomarker research in the field of neurodegeneration. It is important to have reliable biomarkers that increase the accuracy of clinical diagnosis.
In this new whitepaper, Medpace experts discuss current fluid-based biomarkers for various neurodegenerative disease pathologies.
Neuroscience CRO
Accelerating Drug Development in Global Neuroscience Clinical Research
Neuroscience clinical research is a key therapeutic focus for Medpace, a full-service clinical research organization (CRO). Sponsors from emerging biotechs to global pharmaceutical companies have trusted Medpace for over 30 years to lead their phase I-IV neuroscience clinical trials spanning adult and pediatric populations in a wide range of neuroscience indications. Leverage our broad experience in advancing new neuroscience treatments and specialized expertise in the design and management of complex neuroscience programs to keep your trial on time and on budget.
